Varices in Early Histological Stage Primary Biliary Cirrhosis
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND/GOALS: Esophageal varices (EV) in early histological stages of primary biliary cirrhosis (PBC) have been recognized but not well defined. We sought to determine the prevalence, clinical characteristics, and predictors of EV in early-stage PBC, as well as to evaluate the effectiveness of recent guidelines regarding EV screening in PBC patients. STUDY: We retrospectively reviewed the charts of 325 PBC patients who had undergone complete evaluation before enrollment into 2 large clinical trials at the Mayo Clinic. RESULTS: Nineteen percent (62/325) of our patient population had EV on esophagogastroduodenoscopy; 6% (8/127) of early-stage PBC patients had EV. Ninety five percent of our PBC patients with varices met at least one of the following conditions: male sex, low albumin (<3.5 g/dL), elevated bilirubin level (≥1.2 mg/dL), and/or prolonged prothrombin time (≥12.9 s). The sensitivity and specificity of these variables in combination to predict the presence of varices were 95% and 55%, respectively. Serum bilirubin ≥1.2 mg/dL and albumin <3.5 were independent predictors of varices with hazard values of 5.4 and 3.5 respectively. CONCLUSIONS: EV can occur in a minority of early-stage PBC patients. Various models may be used to identify PBC patients who are candidates for screening esophagogastroduodenoscopy for EV. Based on adequate performance and its simplicity, we propose that male sex, low albumin, elevated bilirubin, and/or prolonged prothrombin time be used as a model to noninvasively predict EV. Further validation is required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In one study, however, [245] whilst 6% (8/127) of early-stage patients with PBC had varices, 95% of patients with varices, nevertheless had markers of highrisk disease: male sex, low albumin, elevated bilirubin, and/or elevated INR.”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [245]
In the citing paper
“One study showed that 6% of patients with PBC without cirrhosis had varices.(91)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [91]
In the citing paper
“It is important to note that patients with PBC can develop varices even in the absence of established cirrhosis, although in clinical practice pre-sinusoidal varices are relatively unusual.234–236”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [235]
Citations
Cites
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
Garcia-Tsao, G., Sanyal, A. J., Grace, N. D., & Carey, W. (2007) · Hepatology · doi:10.1002/hep.21907 · Cited by 1,722
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Self-citationPrognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Balkau, B., Eschwège, E., Poupon, R., & the UDCA–PBC Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242204 · Cited by 755 · cited 2×
“Exclusion criteria (in both studies) included the following: (1) previous treatment with UDCA, colchicine, corticosteroids, azathioprine, cyclosporine, chlorambucil, methotrexate, or d-penicillamine in the past 3 months; (2) anticipated need for liver transplantation within 1 year; (3) pregnancy; (4) age less than 18…”
BackgroundStaging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Self-citationUrsodeoxycholic acid in the treatment of primary biliary cirrhosis
Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487 · cited 2×
“Exclusion criteria (in both studies) included the following: (1) previous treatment with UDCA, colchicine, corticosteroids, azathioprine, cyclosporine, chlorambucil, methotrexate, or d-penicillamine in the past 3 months; (2) anticipated need for liver transplantation within 1 year; (3) pregnancy; (4) age less than 18…”
BackgroundSelf-citationPRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.
Rubin, E., Schaffner, F., & Pópper, H. (1965) · PubMed Central · Cited by 374
Nakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., et al. (2007) · Hepatology · doi:10.1002/hep.21472 · Cited by 365
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
“In one study, however, [245] whilst 6% (8/127) of early-stage patients with PBC had varices, 95% of patients with varices, nevertheless had markers of highrisk disease: male sex, low albumin, elevated bilirubin, and/or elevated INR.”
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
“(90) Nodular regenerative hyperplasia is a known complication of PBC and should be differentiated from cirrhosis; it may also contribute to portal hypertension in noncirrhotic patients.(91) With the high disease specificity of a positive AMA test, the role of liver biopsy in diagnosing PBC is questionable when ALP act…”
BackgroundSelf-citationCarey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Self-citationHirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Moctezuma-Velazquez, C., Saffioti, F., Tasayco-Huaman, S., Casu, S., Mason, A., Roccarina, D., Vargas, V., Nilsson, J.-E., Tsochatzis, E., Augustin, S., et al. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0265-7 · Cited by 78
Lammert, C. S., Juran, B. D., Schlicht, E. M., Chan, L. L., Atkinson, E. J., de Andrade, M., & Lazaridis, K. N. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0903-1 · Cited by 50
“This may have created a biased perspective, specifically since portal hypertensive outcomes have been seen in any stage of fibrosis in PBC patients [17].”
Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis
Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A., & Lindor, K. D. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1132337 · Cited by 47
“[28,29] We observed a more progressive disease course among the AMA negative patients, despite having statistically significant lower proportion of male patients who are at a higher risk of HCC and early disease esophageal varices.[30,31] It is quite possible that the lack of AMA would delay accurate diagnosis and UDC…”
BackgroundSelf-citationSymptoms of PBC – Pathophysiology and management
Khanna, A., Leighton, J., Wong, L. L., & Jones, D. E. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.007 · Cited by 49
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice
Invernizzi, F., Cilla, M., Trapani, S., Guarino, M., Cossiga, V., Gambato, M., Morelli, M. C., Morisco, F., Burra, P., & Floreani, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060925 · Cited by 45
“that fatigue is more associated with female sex at PBC presentation [41,42,44,45,48,51].”
BackgroundReview article: pathophysiology and management of primary biliary cholangitis
Leung, K. K., Deeb, M., & Hirschfield, G. M. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16023 · Cited by 40
A validated clinical tool for the prediction of varices in PBC: The Newcastle Varices in PBC Score
Patanwala, I., McMeekin, P. J., Walters, R., Mells, G. F., Alexander, G., Newton, J. L., Shah, H., Coltescu, C., Hirschfield, G. M., Hudson, M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.010 · Cited by 43
“0001 138 MABPT [9] 198 n.”
BackgroundMethodResultInfluentialChronic Complications of Cholestasis
Assis, D. N. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.03.014 · Cited by 36
Warnes, T. W., Roberts, S. A., Smith, A., Cope, V. M., Vales, P., Haboubi, N. Y., & McMahon, R. F. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002033 · Cited by 37
Patel, A., & Seetharam, A. B. (2016) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2016.10.001 · Cited by 36
“Portal hypertensive-related complications including gastroesophageal varices might develop prior to advanced stages of fibrosis.(5) Classically, ursodeoxycholic acid was well established as the only therapy in retarding disease progression and improving survival, especially when initiated in early stages.”
BackgroundRecent advances in the diagnosis and treatment of primary biliary cholangitis
Huang, Y.-Q. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i33.1419 · Cited by 31
Evolving strategies for liver fibrosis staging: The non-invasive assessment
Stasi, C., & Milani, S. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i2.191 · Cited by 27
Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis
Ikeda, F., Okamoto, R., Baba, N., Fujioka, S., Shoji, B., Yabushita, K., Ando, M., Matsumura, S., Kubota, J., Yasunaka, T., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07114.x · Cited by 24
Diagnosis and management of primary biliary cirrhosis
Ali, A. H., Carey, E. J., & Lindor, K. D. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.979792 · Cited by 24
“Unlike other liver diseases, patients with early histological stage PBC can develop portal hypertension and gastroesophageal varices [107,108].”
BackgroundSelf-citationBiomarkers for primary biliary cholangitis: current perspectives
Kouroumalis, E., Samonakis, D., & Voumvouraki, A. (2018) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s135337 · Cited by 26
“clinical outcome although one should keep in mind that fatal complications in PBC may develop before cirrhosis.(82)”
Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC)
Janmohamed, A., & Trivedi, P. J. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.002 · Cited by 21
Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases
Dalekos, G. Ν., & Gatselis, N. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00550-9 · Cited by 23
Carbone, M., Gerussi, A., Cardinale, V., Cazzagon, N., Cossiga, V., Lleò, A., Marrone, G., Marzioni, M., Moschetta, A., Muratori, L., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.05.002 · Cited by 18
Novel strategies and therapeutic options for the management of primary biliary cholangitis
Khanna, A., & Jones, D. E. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17728669 · Cited by 16
Rigamonti, C., Cittone, M. G., Manfredi, G. F., De Benedittis, C., Paggi, N., Baorda, F., Di Benedetto, D., Minisini, R., & Pirisi, M. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100952 · Cited by 15
Prediction of oesophageal varices in patients with primary biliary cirrhosis by non-invasive markers
Gao, L., Meng, F., Cheng, J., Li, H., Han, J., & Zhang, W. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.65450 · Cited by 15
“[9] reported that male sex, low albumin, elevated bilirubin, and/ or prolonged prothrombin time are the predictors for the development of oesophageal varices in early PBC.”
BackgroundZhang, Y., Lai, H., Chen, J., Lai, R., Lin, X., Lin, S., Liu, B., Lin, Q., Wang, B., & Zheng, Q. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101577 · Cited by 18
Calvaruso, V., Celsa, C., Cristoferi, L., Scaravaglio, M., Smith, R. J., Kaur, S., Maria, G. D., Capodicasa, L., Pennisi, G., Gerussi, A., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.10.020 · Cited by 21
Stasi, C., Leoncini, L., Biagini, M. R., Arena, U., Madiai, S., Laffi, G., Marra, F., & Milani, S. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.10.024 · Cited by 16
Precirrhotic Primary Biliary Cholangitis with Portal Hypertension: Bile Duct Injury Correlate
Hu, Y.-F., Li, S.-X., Liu, H.-L., Du, Z.-X., Wang, S.-S., Chen, M., Wang, L., Xiong, Q., Zhong, Y.-D., Liu, D.-X., et al. (2024) · Gut and Liver · doi:10.5009/gnl230468 · Cited by 16
“Furthermore, this method may overlook some patients with extraesophageal varices and cannot fully represent the patients with PH. 7,10 Related studies have proved that varicose veins can be evaluated by imaging examination, and it has high sensitivity and specificity, which can be used in the…”
BackgroundMethodResultInfluentialRisk Stratification in Primary Biliary Cholangitis
Martini, F., Balducci, D., Mancinelli, M., Buzzanca, V., Fracchia, E., Tarantino, G., Benedetti, A., Marzioni, M., & Maroni, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175713 · Cited by 13
Management of Fatigue in Primary Biliary Cholangitis
Khanna, A., Hegade, V. S., & Jones, D. E. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00458-0 · Cited by 11
Chang, J. P.-E., Tan, C., Cheah, C.-C., Li, J. W., Chow, W. C., & Wong, Y. J. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06334-y · Cited by 10
Yan, Y., Xing, X., Wang, X., & Yang, L. J. (2021) · European Radiology · doi:10.1007/s00330-021-08280-3 · Cited by 10
“Varices present in up to 15% of patients with PBC in non-advanced disease stage [38, 39].”
Primary biliary cholangitis: current insights and novel therapies
Granito, A., Παππάς, Γ., Napoli, L., Stefanini, B., Tirotta, D., & Muratori, P. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2672493 · Cited by 9
“However, in contrast to other chronic liver diseases, portal hypertension can occur in PBC even before cirrhosis develops, with approximately 5–6% of patients developing esophageal varices in the early stages of the disease [79,80].”
Autorinnen/Autoren, & Collaborators (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2558-5204 · Cited by 10
Primary biliary cirrhosis: Is there still a place for histological evaluation?
Nakanuma, Y. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.07.011 · Cited by 6
“[8] Ali AH, Sinakos E, Silveira MG, et al.”
BackgroundBaveno-VI–Guided Prediction of Esogastric Varices in Primary Biliary Cholangitis
Pariente, A. E., Chazouillères, O., Causse, X., Hanslik, B., Arpurt, J., Henrion, J., Rosa, I., Renou, C., Corpechot, C., & for the Group of Investigators of DESCRIPT 1 and 2 Studies (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000056 · Cited by 6
Moharm, A. E. A., El-Kalla, F., Kobtan, A. A., & Elkhalawany, W. A. (2022) · The Open Biomarkers Journal · doi:10.2174/18753183-v12-e2112230 · Cited by 5
Invernizzi, P., Leung, P. S. C., Ma, X., & Gershwin, M. E. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_18 · Cited by 5
Yan, Y., Xing, X., Lu, Q., Wang, X., Men, R., Luo, X., & Yang, L. J. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1884071 · Cited by 4
“more, varices are present in up to 15% patients with PBC in non-advanced disease stage [6,7].”
BackgroundThe impact of male sex on outcomes in primary biliary cholangitis
Walia, N., Pohl, J., Reinhardt, M., Pavlidis, C., French, J., Demir, M., Tacke, F., & Engelmann, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-44615-0 · Cited by 2
“Prior research has also demonstrated worse outcomes for males with PBC with respect to mortality 10,12,30 but these findings have been inconsistent or have been limited in their assessment of disease severity 31–33 .”
Sebode, M., Bantel, H., Baumann, U., Bufler, P., Demir, M., Dold, L., Keitel, V., Klein, R., Kremer, A. E., Jansen, P. L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2475 · Cited by 2
Case 4-2023: A 56-Year-Old Man with Abnormal Results on Liver Testing
Bhan, I., Schaefer, E. A. K., Bradley, W. R., Rodriguez‐Lopez, J., Crowley, J., & Hutchison, B. M. (2023) · New England Journal of Medicine · doi:10.1056/nejmcpc2201249 · Cited by 1
Han, L., Xie, H., Ma, X., Lu, X.-L., Zhao, J., Liang, Q., Zou, Z., Bi, J., Jin, B., & Sun, Y. H. (2024) · iLiver · doi:10.1016/j.iliver.2024.100081 · Cited by 3
“The portal pressure increased in 72% of patients with early-stage PBC, and 6% of these patients had esophageal varices; additionally, portal hypertension appeared in 82% of patients with pre-cirrhotic PBC [23,24].”
Autoimmune Liver Diseases: Primary Biliary Cholangitis
Ali, A. H., Carey, E. J., & Lindor, K. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_16
Self-citationTransplant and Autoimmune Diseases
Gambato, M., & Russo, F. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-65908-0_16
Shear Wave Elastography for Liver Disease: Part 2
Rosselli, M., Sporea, I., & Ferraioli, G. (2023) · Wiley eBooks · doi:10.1002/9781119612650.ch9.2
[Research progress on early-stage primary biliary cholangitis accompanied by portal hypertension].
Ma, L., Shen, L. H., Li, S. X., Duan, W. J., Jia, J., & You, H. (2025) · PubMed Central · doi:10.3760/cma.j.cn501113-20250505-00172 · Cited by 2
Wang, X., Zhang, L., Liu, S., Zhang, T., Wang, T., & Zhong, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1696121
Huang, L.-X., & Feng, B. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i4.318
Metadata
- Authors
- Ali, A. H., Sinakos, E., Silveira, M. G., Jorgensen, R. A., Angulo, P., & Lindor, K. D.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2011-08
- Volume
- 45
- Issue
- 7
- Pages
- e66-e71
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2139223881
- Cited by
- 50
- References
- 27
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 4 · 2016: 4 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 1
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary biliary cirrhosis, esophageal varices, variceal screening, upper gastrointestinal endoscopy, serum albumin, serum bilirubin, prothrombin time, risk factors, non-invasive prediction model
- MeSH terms
- Adult, Aged, Cholagogues and Choleretics, Double-Blind Method, Esophageal and Gastric Varices, Female, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Sensitivity and Specificity, Ursodeoxycholic Acid, Prevalence, Endoscopy, Gastrointestinal, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.